Show simple item record

dc.contributor.authorTivey, Ann
dc.contributor.authorUllah, M
dc.contributor.authorBeech, A
dc.contributor.authorNg, C
dc.contributor.authorCove-Smith, Laura
dc.date.accessioned2020-04-22T07:25:10Z
dc.date.available2020-04-22T07:25:10Z
dc.date.issued2020en
dc.identifier.citationTivey A, Ullah M, Beech A, Ng C, Cove-Smith L. Can frailty screening tools predict completion of chemotherapy and chemotherapy toxicity in patients with thoracic malignancy? J Geriatr Oncol. 2020.en
dc.identifier.pmid32171694en
dc.identifier.doi10.1016/j.jgo.2020.03.002en
dc.identifier.urihttp://hdl.handle.net/10541/622925
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.jgo.2020.03.002en
dc.titleCan frailty screening tools predict completion of chemotherapy and chemotherapy toxicity in patients with thoracic malignancy?en
dc.typeArticleen
dc.contributor.departmentThe Christie NHS Foundation Trust, United Kingdom; Manchester University NHS Foundation Trust, United Kingdomen
dc.identifier.journalJournal of Geriatric Oncologyen
dc.description.noteen]
refterms.dateFOA2020-04-22T11:32:38Z


Files in this item

Thumbnail
Name:
32171694.pdf
Size:
280.6Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record